121 related articles for article (PubMed ID: 20552225)
1. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.
Kim BK; Park JY; Choi HJ; Kim DY; Ahn SH; Kim JK; Lee DY; Lee KH; Han KH
J Cancer Res Clin Oncol; 2011 Apr; 137(4):659-67. PubMed ID: 20552225
[TBL] [Abstract][Full Text] [Related]
2. Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan.
Nouso K; Miyahara K; Uchida D; Kuwaki K; Izumi N; Omata M; Ichida T; Kudo M; Ku Y; Kokudo N; Sakamoto M; Nakashima O; Takayama T; Matsui O; Matsuyama Y; Yamamoto K;
Br J Cancer; 2013 Oct; 109(7):1904-7. PubMed ID: 24008659
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.
Fu S; Xu Y; Mao Y; He M; Chen Z; Huang S; Li D; Lv Y; Wu J
Cancer Med; 2024 May; 13(9):e7105. PubMed ID: 38686567
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F
World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of targeted therapy plus immunotherapy combined with hepatic artery infusion chemotherapy (FOLFOX) for unresectable hepatocarcinoma.
Lin ZP; Hu XL; Chen D; Huang DB; Zou XG; Zhong H; Xu SX; Chen Y; Li XQ; Zhang J
World J Gastroenterol; 2024 May; 30(17):2321-2331. PubMed ID: 38813052
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.
Mizukoshi E; Yamashita T; Arai K; Terashima T; Kitahara M; Nakagawa H; Iida N; Fushimi K; Kaneko S
Cancer Immunol Immunother; 2016 Jun; 65(6):715-25. PubMed ID: 27083166
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma.
Xiao Y; Deng W; Luo L; Zhu G; Xie J; Liu Y; Wan R; Wen W; Hu Z; Shan R
BMC Cancer; 2024 May; 24(1):588. PubMed ID: 38745113
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of optimal treatment response rates in patients undergoing hepatic arterial infusion chemotherapy combined with molecular targeting and immunotherapy.
Li M; Liao J; Wang L; Lv T; Sun Q; Xu Y; Guo Z; Quan M; Qin H; Yu H; Zhang K; Xing W; Yu H
Front Immunol; 2024; 15():1303259. PubMed ID: 38660298
[TBL] [Abstract][Full Text] [Related]
9. Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study.
An C; Wei R; Yao W; Han W; Li W; Shi G; Wu P
Cancer Med; 2024 Jun; 13(11):e7319. PubMed ID: 38819606
[TBL] [Abstract][Full Text] [Related]
10. Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma.
Chen CT; Liu TH; Shao YY; Liu KL; Liang PC; Lin ZZ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884684
[TBL] [Abstract][Full Text] [Related]
11. Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma.
Park SH; Lee Y; Han SH; Kwon SY; Kwon OS; Kim SS; Kim JH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
BMC Cancer; 2006 Jan; 6():3. PubMed ID: 16396674
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.
Ikeda M; Yamashita T; Ogasawara S; Kudo M; Inaba Y; Morimoto M; Tsuchiya K; Shimizu S; Kojima Y; Hiraoka A; Nouso K; Aikata H; Numata K; Sato T; Okusaka T; Furuse J
Liver Cancer; 2024 Apr; 13(2):193-202. PubMed ID: 38751550
[TBL] [Abstract][Full Text] [Related]
13. The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma.
Ding Y; Wang S; Qiu Z; Zhu C; Wang Y; Zhao S; Qiu W; Wang K; Lv J; Qi W
Front Immunol; 2023; 14():1284937. PubMed ID: 38022559
[TBL] [Abstract][Full Text] [Related]
14. Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review.
Zhu S; Yu Y; Yang M; Liu X; Lai M; Zhong J; Zhao X; Lu L; Liu Y
Expert Rev Anticancer Ther; 2024 Jun; 24(6):423-434. PubMed ID: 38651280
[TBL] [Abstract][Full Text] [Related]
15. Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
Lin W; Lu L; Zheng R; Yuan S; Li S; Ling Y; Wei W; Guo R
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17231-17239. PubMed ID: 37801135
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study.
Ikuta S; Aihara T; Yamanaka N
Contemp Oncol (Pozn); 2018; 22(3):165-171. PubMed ID: 30455588
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil.
Ueshima K; Kudo M; Tanaka M; Kumada T; Chung H; Hagiwara S; Inoue T; Yada N; Kitai S
Liver Cancer; 2015 Dec; 4(4):263-73. PubMed ID: 26734580
[TBL] [Abstract][Full Text] [Related]
18. A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
Changou CA; Shiah HS; Chen LT; Liu S; Luh F; Liu SH; Cheng YC; Yen Y
Oncologist; 2021 Mar; 26(3):e367-e373. PubMed ID: 33140457
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics, Treatment Patterns, and Outcomes of Patients With Locally Advanced/Metastatic Hepatocellular Carcinoma Treated at the Veterans Health Administration.
Alkadimi MA; Aldawoodi TA; Lucero KT; Fierro ME; Boyle LD; Mader MJ; Franklin KR; Arora SP; Nooruddin Z
Oncologist; 2024 May; 29(5):369-376. PubMed ID: 38254242
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study.
Xue T; Yu H; Feng W; Wang Y; Wu S; Wang L; Zhu P; Guan J; Sun Q
Cancer Manag Res; 2024; 16():163-175. PubMed ID: 38505102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
